跳至主要内容
临床试验/NCT04552405
NCT04552405已完成不适用

Preventive Anti-inflammatory Diet to Reduce Gastro-intestinal Inflammation in FAP Patients: a Prospective Pilot Study

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2017年9月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
35
试验地点
1
主要终点
Evaluate changes in calprotectin levels

研究概览

简要总结

Preventive anti-inflammatory diet to reduce gastro-intestinal inflammation in FAP patients: a prospective pilot study

详细描述

a prospective pilot study

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •FAP patients carrying mutations in APC gene, submitted to prophylactic total colectomy/IRA (with rectum preservation) and that participate to the regular endoscopic surveillance program at IRCCS-INT.

排除标准

  • •FAP patients taking NSAIDs and/or Omega 3
  • •Patients who carried MUTYH germline mutations or had no APC mutation found.

研究组 & 干预措施

FAP patients

Other

FAP patients who underwent prophylactic total colectomy

干预措施: Anti-inflammatory Diet (Dietary Supplement)

结局指标

主要结局

Evaluate changes in calprotectin levels

时间窗: baseline, at 3 months and 6 months post anti-inflammatory diet consumption.

Change from baseline in calprotectin levels at 3 months and 6 months post anti-inflammatory diet consumption.

次要结局

  • Evaluate changes in circulatory inflammatory markers(baseline, at 3 months and 6 months post anti-inflammatory diet consumption.)
  • Evaluate the effect on polyps growth(baseline and 6 months post anti-inflammatory diet consumption)
  • Evaluate changes in the number of diarrheal discharges(baseline, at 3 months and 6 months post anti-inflammatory diet consumption)
  • Evaluate changes in the immune cell profile(baseline, at 3 months and 6 months post anti-inflammatory diet consumption)
  • Evaluate changes in stool inflammatory markers(baseline, at 3 months and 6 months post anti-inflammatory diet consumption)

研究者

发起方
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验